Lexicon Pharmaceuticals, Inc. financial data

Symbol
LXRX on Nasdaq
Industry
Pharmaceutical Preparations
Location
2445 Technology Forest Blvd., Suite 1100, The Woodlands, TX
State of incorporation
DE
Fiscal year end
December 31
Former names
LEXICON PHARMACEUTICALS, INC./DE (to 12/5/2014), LEXICON GENETICS INC/TX (to 4/2/2007)
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 951 % +31.4%
Quick Ratio 1.78 %
Debt-to-equity 67.5 % -14.4%
Return On Equity -108 % +9.06%
Return On Assets -64.5 % +2.87%
Operating Margin -4.04K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 361M shares +47.6%
Entity Public Float 274M USD +104%
Common Stock, Value, Issued 363K USD +48.2%
Weighted Average Number of Shares Outstanding, Basic 361M shares +47.6%
Weighted Average Number of Shares Outstanding, Diluted 361M shares +47.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 5.23M USD +980%
Revenue from Contract with Customer, Excluding Assessed Tax 5.12M USD +1076%
Research and Development Expense 72.6M USD +24.9%
Costs and Expenses 216M USD +31.4%
Operating Income (Loss) -211M USD -35.9%
Net Income (Loss) Attributable to Parent -216M USD -37.1%
Earnings Per Share, Basic -0.75 USD/shares +2.6%
Earnings Per Share, Diluted -0.75 USD/shares +14.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 34.6M USD +63.6%
Accounts Receivable, after Allowance for Credit Loss, Current 2.9M USD +810%
Inventory, Net 636K USD +89.3%
Other Assets, Current 6.71M USD +56.3%
Assets, Current 269M USD +20.3%
Property, Plant and Equipment, Net 2.14M USD +0.05%
Operating Lease, Right-of-Use Asset 5.01M USD -11.9%
Goodwill 44.5M USD 0%
Other Assets, Noncurrent 828K USD +11.4%
Assets 321M USD +16.1%
Accounts Payable, Current 14.2M USD +18%
Employee-related Liabilities, Current 11.2M USD +14.3%
Accrued Liabilities, Current 21.8M USD +8.01%
Liabilities, Current 36M USD +11.7%
Long-term Debt and Lease Obligation 5.48M USD +447%
Operating Lease, Liability, Noncurrent 4.68M USD -14.1%
Other Liabilities, Noncurrent 6.67M USD
Liabilities 143M USD +4.12%
Accumulated Other Comprehensive Income (Loss), Net of Tax 349K USD
Retained Earnings (Accumulated Deficit) -1.93B USD -12.6%
Stockholders' Equity Attributable to Parent 179M USD +28%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 179M USD +28%
Liabilities and Equity 321M USD +16.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -55.1M USD -74.4%
Net Cash Provided by (Used in) Financing Activities 239M USD
Net Cash Provided by (Used in) Investing Activities -110M USD -1011%
Common Stock, Shares Authorized 450M shares
Common Stock, Shares, Issued 363M shares +47.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 74M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 34.6M USD +63.6%
Interest Paid, Excluding Capitalized Interest, Operating Activities 3.26M USD +109%
Deferred Tax Assets, Valuation Allowance 390M USD +12.8%
Cash and Cash Equivalents, Period Increase (Decrease) -4.55M USD +84.1%
Deferred Tax Assets, Gross 392M USD +12.9%
Operating Lease, Liability 5.98M USD -11.2%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -216M USD -37.1%
Lessee, Operating Lease, Liability, to be Paid 8.96M USD -13.3%
Property, Plant and Equipment, Gross 4.1M USD
Operating Lease, Liability, Current 1.3M USD +0.78%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.22M USD -11.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 345K USD +2.07%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 Rate 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.98M USD -17.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 865K USD -29.1%
Deferred Tax Assets, Operating Loss Carryforwards 288M USD +14.7%
Preferred Stock, Shares Issued 2.3M shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 881K USD +1.85%
Additional Paid in Capital 2.12B USD +13.8%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 144K USD +28.6%
Share-based Payment Arrangement, Expense 15.2M USD -28.2%
Operating Leases, Future Minimum Payments, Due in Three Years 1.22M USD +124%
Operating Leases, Future Minimum Payments Due 10.8M USD +314%
Interest Expense 8.78M USD +345%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%